S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
RATIONALE: Serotonin (5-HT)(2C) receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive states. OBJECTIVES: Herein, we characterized the in vitro and in vivo pharmacological profile of the novel benzourea derivative, S32006....
Prif Awduron: | Dekeyne, A, Mannoury la Cour, C, Gobert, A, Brocco, M, Lejeune, F, Serres, F, Sharp, T, Daszuta, A, Soumier, A, Papp, M, Rivet, J, Flik, G, Cremers, T, Muller, O, Lavielle, G, Millan, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2008
|
Eitemau Tebyg
-
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
gan: Millan, M, et al.
Cyhoeddwyd: (2004) -
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
gan: Dekeyne, A, et al.
Cyhoeddwyd: (2012) -
Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
gan: Karolina Pytka, et al.
Cyhoeddwyd: (2015-01-01) -
Brain Targeting of Antidepressant and Anxiolytic Drugs
gan: Jéssica Antunes, et al.
Cyhoeddwyd: (2022-12-01) -
Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
gan: Wesołowska A, et al.
Cyhoeddwyd: (2021-06-01)